Celularity Liabilities And Stockholders Equity from 2010 to 2024

CELU Stock  USD 3.43  0.21  5.77%   
Celularity Liabilities And Stockholders Equity yearly trend continues to be comparatively stable with very little volatility. Liabilities And Stockholders Equity will likely drop to about 338.4 M in 2024. Liabilities And Stockholders Equity is the total of all liabilities and equity in the company, which should equal Celularity's total assets according to the accounting equation. View All Fundamentals
 
Liabilities And Stockholders Equity  
First Reported
2010-12-31
Previous Quarter
461.2 M
Current Value
338.4 M
Quarterly Volatility
201 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Celularity financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Celularity main balance sheet or income statement drivers, such as Interest Expense of 2.5 M, Net Income Applicable To Common Shares of 17.1 M or Income Tax Expense of 15.7 K, as well as many exotic indicators such as Price To Sales Ratio of 15.57, Dividend Yield of 0.0 or PTB Ratio of 1.06. Celularity financial statements analysis is a perfect complement when working with Celularity Valuation or Volatility modules.
  
This module can also supplement Celularity's financial leverage analysis and stock options assessment as well as various Celularity Technical models . Check out the analysis of Celularity Correlation against competitors.
For more information on how to buy Celularity Stock please use our How to Invest in Celularity guide.

Latest Celularity's Liabilities And Stockholders Equity Growth Pattern

Below is the plot of the Liabilities And Stockholders Equity of Celularity over the last few years. It is the total of all liabilities and equity in the company, which should equal the company's total assets according to the accounting equation. Celularity's Liabilities And Stockholders Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Celularity's overall financial position and show how it may be relating to other accounts over time.
Liabilities And Stockholders Equity10 Years Trend
Slightly volatile
   Liabilities And Stockholders Equity   
       Timeline  

Celularity Liabilities And Stockholders Equity Regression Statistics

Arithmetic Mean155,930,624
Geometric Mean3,794,964
Coefficient Of Variation128.91
Mean Deviation186,907,400
Median174,457
Standard Deviation201,007,552
Sample Variance40404T
Range461.1M
R-Value0.85
Mean Square Error12239.5T
R-Squared0.72
Significance0.000066
Slope38,104,335
Total Sum of Squares565656.5T

Celularity Liabilities And Stockholders Equity History

2024338.4 M
2023461.2 M
2022401.1 M
2021414.1 M
2020431 M
2019291.6 M

About Celularity Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Celularity income statement, its balance sheet, and the statement of cash flows. Celularity investors use historical funamental indicators, such as Celularity's Liabilities And Stockholders Equity, to determine how well the company is positioned to perform in the future. Although Celularity investors may use each financial statement separately, they are all related. The changes in Celularity's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Celularity's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Celularity Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Celularity. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Liabilities And Stockholders Equity461.2 M338.4 M
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Celularity in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Celularity's short interest history, or implied volatility extrapolated from Celularity options trading.

Pair Trading with Celularity

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Celularity position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Celularity will appreciate offsetting losses from the drop in the long position's value.

Moving together with Celularity Stock

  0.61JNJ Johnson Johnson Aggressive PushPairCorr

Moving against Celularity Stock

  0.5MRK Merck Company Financial Report 6th of August 2024 PairCorr
The ability to find closely correlated positions to Celularity could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Celularity when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Celularity - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Celularity to buy it.
The correlation of Celularity is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Celularity moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Celularity moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Celularity can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Celularity is a strong investment it is important to analyze Celularity's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Celularity's future performance. For an informed investment choice regarding Celularity Stock, refer to the following important reports:
Check out the analysis of Celularity Correlation against competitors.
For more information on how to buy Celularity Stock please use our How to Invest in Celularity guide.
You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Complementary Tools for Celularity Stock analysis

When running Celularity's price analysis, check to measure Celularity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celularity is operating at the current time. Most of Celularity's value examination focuses on studying past and present price action to predict the probability of Celularity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celularity's price. Additionally, you may evaluate how the addition of Celularity to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Is Celularity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Celularity. If investors know Celularity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Celularity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.93)
Earnings Share
(10.30)
Revenue Per Share
0.887
Quarterly Revenue Growth
(0.08)
Return On Assets
(0.20)
The market value of Celularity is measured differently than its book value, which is the value of Celularity that is recorded on the company's balance sheet. Investors also form their own opinion of Celularity's value that differs from its market value or its book value, called intrinsic value, which is Celularity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Celularity's market value can be influenced by many factors that don't directly affect Celularity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Celularity's value and its price as these two are different measures arrived at by different means. Investors typically determine if Celularity is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Celularity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.